RecruitingPhase 2NCT07523581
Rare condition
Autosomal recessive Alport syndrome
2
studies recruiting now
as of 7 Sept 2026
4
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
13 Apr 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT06065852
National Registry of Rare Kidney Diseases
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Autosomal recessive Alport syndrome studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Autosomal recessive Alport syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Autosomal recessive Alport syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (COL4A3, COL4A4).
Treatments being studied
10 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Bardoxolone Methyl
Phase 2/3Solizmestrocel
Phase 2Elx-02
Phase 2Vonafexor
Phase 2Lademirsen
Phase 2Valsartan (Diovan)
Phase 2Benazepril
Phase 2Fluvastatin
+ 2 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).